Tenderfy

EMBED 3.0 - Improvement of Formulations

Pirkėjas
Cardiff University
Paskelbta
2026-10-19
Terminas
Nenurodyta
Šaltiniai
UK_FTS
Vertė
Nenurodyta

Aprašymas

Aprašymas pateikiamas šaltinio kalba.

The B&M Gates Foundation (funder) have reviewed the work with the EMBED research team, undertaken with the manufacturer ProMed, and have decided that to push the EMBED 3.0 project into its next stage (EMBED 4.0 – Human Trials), they’ll need to demonstrate their ability to vary the additional batches offer a more robust mechanism for the medications to enter patients. The additional work has been again funded by the foundation for the purpose of increasing the viability of the delivery method (technology developed as part of EMBED) - Previous direct award for the initial development via Regulation 41 - Schedule 5, para 2.

Narystė

Peržiūrėkite skelbimo santrauką nemokamai. Oficialaus skelbimo ir dokumentų nuorodoms, statybos leidimams bei asmeninei MCP prieigai reikia aktyvios mokamos narystės.

Skaityti